Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus for Functional Recovery After Peripheral Nerve Injury
NCT00950391Phase 2Withdrawn
- Sponsor
- Washington University School of Medicine
- Start
- Aug 2010
- Primary completion
- Sep 2014
- Modality
- RNA-Targeting Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in peripheral nerve injury (PNI) comparing Tacrolimus with Placebo (2 arms). Primary endpoints: Functional Recovery at 1.5 years and Incidence of adverse events at 1 year. Planned start Aug 2010; status: withdrawn.
02
Drugs
tacrolimus
03
Conditions
peripheral nerve injury (PNI)
Beyond the preview
Go deeper on NCT00950391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00950391.